AlphaQuest LLC Lowers Position in Option Care Health, Inc. $OPCH

Key Points

• AlphaQuest LLC has reduced its stake in Option Care Health, Inc. by 77.7%, now owning 5,246 shares valued at $183,000 after selling 18,274 shares in the first quarter.
• Several institutional investors, including Compass Wealth Management and Bessemer Group, have increased their holdings in Option Care Health during the same period, emphasizing strong institutional interest.
• Analysts are optimistic, with eight rating the stock as a Buy and setting an average target price of $35.75, following the company’s better-than-expected earnings report.

AlphaQuest LLC trimmed its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 77.7% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,246 shares of the company's stock after selling 18,274 shares during the quarter. AlphaQuest LLC's holdings in Option Care Health were worth $183,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Compass Wealth Management LLC grew its holdings in Option Care Health by 8.9% in the first quarter. Compass Wealth Management LLC now owns 166,078 shares of the company's stock valued at $5,804,000 after purchasing an additional 13,600 shares during the period. Bessemer Group Inc. grew its holdings in Option Care Health by 62.3% in the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after purchasing an additional 599 shares during the period. Principal Financial Group Inc. grew its stake in Option Care Health by 1.4% during the first quarter. Principal Financial Group Inc. now owns 485,871 shares of the company's stock worth $16,981,000 after buying an additional 6,616 shares during the period. Wealth Enhancement Advisory Services LLC grew its stake in Option Care Health by 25.7% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company's stock worth $289,000 after buying an additional 1,691 shares during the period. Finally, GAMMA Investing LLC grew its stake in Option Care Health by 307.1% during the first quarter. GAMMA Investing LLC now owns 3,192 shares of the company's stock worth $112,000 after buying an additional 2,408 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on OPCH shares. Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Barrington Research reiterated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research note on Thursday, July 10th. Finally, JMP Securities boosted their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research note on Thursday, July 31st. Eight analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $35.75.

Option Care Health Price Performance

Shares of OPCH stock opened at $28.68 on Friday. The company has a market capitalization of $4.65 billion, a PE ratio of 22.94, a price-to-earnings-growth ratio of 1.75 and a beta of 0.79. The firm has a fifty day simple moving average of $29.60 and a 200-day simple moving average of $31.65. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.01. The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business's quarterly revenue was up 15.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Equities research analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Insider Buying and Selling at Option Care Health

In other news, Director Timothy P. Sullivan bought 20,000 shares of the firm's stock in a transaction dated Thursday, August 21st. The stock was acquired at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the purchase, the director owned 49,229 shares of the company's stock, valued at $1,354,289.79. This trade represents a 68.43% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of the firm's stock in a transaction dated Wednesday, August 20th. The stock was purchased at an average price of $27.15 per share, with a total value of $977,400.00. Following the completion of the purchase, the director directly owned 375,390 shares of the company's stock, valued at approximately $10,191,838.50. This trade represents a 10.61% increase in their position. The disclosure for this purchase can be found here. 0.64% of the stock is currently owned by corporate insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.